Immunomedics regulatory update

IMMU received two patents and a notice of allowance from the Japanese Patent Office covering its imaging and therapy technologies. Patent No. 1,996,023 covers radiolabeled antibodies and fragments against a variety of substances used to treat cancers.

Patent No. 2,021,475 covers the use of anti-antibodies to reduce the deposition of therapeutic antibodies in normal tissues. ...